NCT05382442 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05382442
Title	A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Akeso
Indications	colorectal adenocarcinoma
Therapies	Ivonescimab Fluorouracil + Ivonescimab + Leucovorin + Oxaliplatin AK117 + Fluorouracil + Irinotecan + Ivonescimab + Leucovorin + Oxaliplatin AK117 + Fluorouracil + Ivonescimab + Leucovorin AK117 + Capecitabine + Ivonescimab + Oxaliplatin AK117 + Capecitabine + Ivonescimab Fluorouracil + Ivonescimab + Leucovorin AK117 + Ivonescimab Capecitabine + Ivonescimab + Oxaliplatin Fluorouracil + Irinotecan + Ivonescimab + Leucovorin + Oxaliplatin
Age Groups:	adult \| senior
Covered Countries	USA

Facility	City	State	Zip	Country	Details
Summit Therapeutics Research Site	Los Angeles	California	90067	United States	Details
Summit Therapeutics Research Site	Murrieta	California	92562	United States	Details
Summit Therapeutics Research Site	Fairfax	Virginia	22031	United States	Details
The Sixth Hospital,Sun Yat-sen University	Guanzhou	Guangdong	510000	China	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT05382442Clinical Trial Detail